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Background: Elderly patients may be at risk of suboptimal care. Thus, the relationship between age and quality of care for
patients hospitalized for heart failure was examined. Methods: A cross-sectional study based on retrospective chart review was
performed among a random sample of patients hospitalized between 1996 and 1998 in the general internal medicine wards,
with a principal diagnosis of congestive heart failure, and discharged alive. Explicit criteria of quality of care, grouped into three
scores, were used: admission work-up (admission score); evaluation and treatment during the stay (evaluation and treatment
score); and readiness for discharge (discharge score). The associations between age and quality of care scores were analysed
using linear regression models. Results: Charts of 371 patients were reviewed. Mean age was 75.7 (±11.1) years and 52%
were men. There was no relationship between age and admission or readiness for discharge scores. The evaluation and treatment
score decreased with age: compared with patients less than 70 years old, the score was lower by –2.6% (95% CI: –7.1 to1.9)
for patients aged 70 to 79, by –8.7% (95% CI: –13.0 to –4.3) for patients aged 80 to 89, and by –19.0% (95% CI: –26.6 to
–11.5) for patients aged 90 and over. After adjustment for possible confounders, this relationship was not significantly modified.
Conclusions: In patients hospitalized for congestive heart failure, older age was not associated with lower quality of care scores
except for evaluation and treatment. Whether this is detrimental to elderly patients remains to be evaluated.
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Older patients tend to receive in-hospital treatments proven to
lower mortality less frequently than younger patients. This has
been shown for several acute cardiac conditions, such as unstable
angina pectoris,1 myocardial infarction,2–4 as well as for chronic
cardiac diseases, such as treatment after myocardial infarction5–7
or heart failure.8,9 A similar negative influence of age has been
reported for the use of hemodialysis and kidney transplantation
among patients with end-stage renal failure.10,11 Lower use of
effective therapies among the elderly occurs even though these
patients are at higher risk of mortality and morbidity,12 and even
though survival benefits of effective treatments in older and
younger patients are often equivalent.13,14
Whether in-hospital care of elderly patients is only less intensive,
or generally worse than that of younger patients, remains unclear.
We addressed this question by applying explicit criteria of quality
of hospital care15 to charts of patients hospitalized for congestive
heart failure, the most frequent diagnosis related group in the
Department of Internal Medicine of our hospital.
METHODS
Setting and patients
This study was conducted in the general internal medicine
wards of the University Hospitals of Geneva, Switzerland. This
1200-bed urban public hospital is the main community and
teaching hospital for the area. Because of limited resources, not
all patient charts could be reviewed. We therefore drew a random
sample of 371 patient records from the 1084 patients discharged
alive with a principal diagnosis of congestive heart failure
admitted between 1 January 1997 and 31 December 1998.16
Patients were identified using ICD9 – CM codes 398.91; 402.01;
402.11; 402.91; 404.01; 404.03; 404.11; 404.13; 404.91; 404.93;
and 428.17
Outcome variables
The main outcome variable was the quality of in-hospital care
measured by means of explicit criteria developed by Ashton et al.15
(the criteria are available at http://www.medinter.ch/grassh).
The criteria were divided into three subgroups corresponding to
successive hospitalization phases: 1) admission work-up (history,
physical examination and initial tests); 2) evaluation and treat-
ment during the stay; and 3) readiness for discharge. As many
criteria were not applicable to all patients, we calculated the
proportion of fulfilled criteria among those applicable to each
hospitalization phase. Thus, three quality scores were obtained
corresponding to each phase of the hospital stay: an admission
score, an evaluation and treatment score, and a discharge score.
All information was abstracted from patient charts by a trained
nurse.
Predictor variables
The main risk factor analysed was patient age. Other predictors
of quality of care included: 1) socio-demographic data: gender,
and whether the patient lived alone; 2) medical data: known
diagnosis of congestive heart failure, hypertension, diabetes,
history of acute myocardial infarction, cardiac revascularization
by percutaneous transluminal coronary angioplasty or coronary
artery bypass grafting, and intubation during the stay; and 3)
admission physical and laboratory findings: systolic blood
pressure, heart rate, serum sodium, plasma creatinine, rhythm
and/or ST-T wave changes on admission electrocardiogram, and
cardiac ejection fraction. Cardiac ejection fraction measurement
was available in only 172 patients. Comorbidities were assessed
and scored according to Charlson et al.18
Statistical analysis
The association between the proportion of quality of care criteria
met in each score and age was explored using locally weighted
smoothing scatterplots (LOWESS).19 On this basis, only the
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score for which an association with age was observed was further
analysed. The influence of patients’ demographic and clinical
characteristics on the proportion of quality of care criteria ful-
filled was assessed by univariate linear regression. Based on
graphical analyses, age was categorized as follows: less than 70
years; 70 to 79 years; 80 to 89 years; and 90 years and over.
Variables reflecting patients’ demographic and clinical
characteristics that were significantly associated with quality of
care in univariate analysis were incorporated into a multivariate
model. Multiple linear regression analysis was used to evaluate
the association between quality of care and the independent
variables. Two-way interactions between age and other risk
factors were tested as well. Backward elimination was then used
until all remaining variables in the model reached a significance
level of 0.05 or less. The significance of associations between age
and observance of quality of care criteria was tested by trend
tests.20
RESULTS
A total of 371 patients were included. Mean patient age was
75.7 years (± 11.1). Older patients were more likely to be women
(table 1) and to live alone, and less likely to have a history of
myocardial revascularization, myocardial infarction or diabetes
mellitus. Older patients were also less often admitted to an
intensive care unit, and they had a significantly lower mean
Charlson comorbidity index.
Age was not associated with the admission score figure 1(a). The
pattern of association was inconsistent for the discharge score
figure 1(c). However, the evaluation and treatment score clearly
decreased with patient age figure 1(b). Further analyses were
therefore conducted for the latter score only. The mean evalu-
ation and treatment score during the stay was 66.1%
(SD=17.2%). In unadjusted analyses (table 2), a better quality of
care during the stay was positively associated with a history of
myocardial revascularization, a faster heart rate on admission,
intubation during the hospital stay, and a longer length of stay.
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Table 1 Characteristics of the patient sample by age groups
Age (years) n (%)
<70
n=95
70–79
n=116
80–89
n=137
≥90
n=23 p-value
Men 71 (74%) 61 (53%) 55 (40%) 7 (30%) <0.001
Living alone 35 (39%) 48 (42%) 75 (57%) 12 (52%) 0.04
Known prior congestive heart failure 38 (41%) 57 (49%) 50 (38%) 11 (52%) 0.30
History of revascularisation 25 (26%) 34 (29%) 8 (6%) 0 <0.001a
History of myocardial infarction 29 (31%) 51 (44%) 42 (31%) 4 (17%) 0.03
Known hypertension 49 (52%) 73 (63%) 72 (53%) 19 (43%) 0.18
Known diabetes mellitus 23 (24%) 34 (29%) 28 (20%) 1 (4%) 0.04
Hypotension on admission 8 (8%) 6 (5%) 7 (5%) 0 0.51a
Hyponatremia on admission 10 (11%) 13 (11%) 33 (24%) 4 (17%) 0.01
Serum creatinine >265.2 µmol/l on admission 8 (9%) 5 (4%) 3 (2%) 0 0.11a
Non-sinus cardiac rhythm on admission 28 (29%) 42 (36%) 52 (39%) 9 (41%) 0.50
Mean heart rate on admission (bpm ±SD) 98 (28) 89 (22) 92 (24) 92 (19) 0.08b
Mean systolic blood pressure on admission (mmHg ±SD) 141 (30) 149 (32) 148 (28) 154 (25) 0.11b
New ST-T changes on admission 41 (46%) 55 (53%) 70 (56%) 13 (62%) 0.38
Admission to an intensive care unit 24 (25%) 23 (20%) 17 (12%) 1 (4%) 0.02a
Intubation during the stay 4 (4%) 7 (6%) 2 (1%) 0 0.20a
Mean Charlson comorbidity index (points ±SD) 2.8 (2.2) 3.1 (2.2) 2.3 (2.0) 1.8 (1.8) 0.004b
Mean length of stay (days ± SD) 12.8 (10.1) 14.2 (10.0) 12.5 (6.0) 13.7 (7.0) 0.48b
Mean ejection fraction (% ±SD) (n=172) 32 (12) 34 (11) 37 (11) 45 (0) 0.17b
Chi square test except
a: Exact test
b: Analysis of variance
Figure 1 Relationship between age and the proportion of quality of
care criteria met for a) admission work-up; b) evaluation and 
treatment during the stay; and c) readiness for discharge, among 
371 patients discharged alive with a main diagnosis of congestive
heart failure from Geneva University Hospitals, 1999
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In multivariate analyses (table 3), the evaluation and treatment
score was positively associated with a longer length of stay, and
remained negatively associated with age.
The association with age varied from one criterion of quality to
the next (table 4). Age had a gradual negative association with
the performance of an echocardiogram, the measurement of the
ejection fraction if it was previously unknown, the measurement
of creatinine clearance if a renal insufficiency appeared or
worsened during hospitalization, and with a transfer to an
intensive care unit in case of severe or prolonged chest pain.
Among the other criteria unrelated to age, two patterns were
seen. A first category (criteria 6 to 13 in table 4) concerned
criteria that were mainly respected during the hospital stay, with
a proportion of eligible patients in which the criteria were
fulfilled exceeding 60%. The second category (criteria 14 to 19
in table 4) included quality of care criteria that were met by 50%
or less of the eligible patients, regardless of age.
DISCUSSION
Our study showed that, among patients hospitalized for con-
gestive heart failure, older age was associated with lower scores
assessing the completeness of evaluation and treatment during
their stay. Compared with patients less than 70 years old,
significant differences were present for the 80 to 89 years of age
group, and even more for the 90 and over age group. These
differences persisted after adjustment for clinical characteristics
and comorbidities. In contrast, admission and discharge scores
bore no relationship with age.
The fact that two out of three quality of care scores were not
related to age is reassuring. Nevertheless, the findings of a less
complete medical evaluation and treatment among the elderly
are disturbing. The prevalence of congestive heart failure in-
creases with age,21 as do hospital admissions for this medical
condition,22,23 and effective treatments reduce mortality and
morbidity even among very old patients.24–27
Analysis of the fulfilment of each individual criterion of evalu-
ation and treatment according to age reveals that the first five
criteria in table 4, mostly reflecting evaluation, were less and less
observed as age increased. This was particularly true for tests
assessing the severity, the type (systolic or diastolic) and the
causes of heart failure. These omissions may be deleterious to
older patients, since this information is likely to influence
treatment, regardless of age.28 On the other hand, invasive
investigations, such as cardiac catheterization, are more likely to
Table 2 Univariate associations between independent variables and evaluation and treatment score
Covariate
Difference in evaluation 
and treatment score 95% CI p-value
Age category
<70 years Reference – –
70–79 years –2.59 –7.08 – 1.89 0.26
80–89 years –8.67 –12.99 – –4.34 <0.001
≥90 years –19.03 –26.56 – –11.50 <0.001
Male sex 2.96 –0.54 – 6.46 0.09
Living alone –0.66 –4.25 – 2.93 0.72
Known prior congestive heart failure 1.85 –1.77 – 5.48 0.32
History of revascularisation 5.30 0.76 – 9.83 0.02
History of myocardial infarction 0.64 –3.07 – 4.35 0.73
Known hypertension 0.64 –2.88 – 4.18 0.72
Known diabetes mellitus 0.82 –3.34 – 4.98 0.70
Hypotension on admission 0.33 –7.25 – 7.91 0.93
Hyponatremia on admission –3.18 –7.95 – 1.58 0.19
Serum creatinine >265.2 µmol/l on admission 2.24 –6.41 – 10.89 0.61
Non-sinus cardiac rhythm on admission 1.97 –1.68 – 5.63 0.29
Heart rate on admission (for 10 bpm increase) 0.8 0.10 – 1.53 0.03
Systolic blood pressure on admission (for 10 mmHg increase) –0.16 –0.75 – 0.43 0.59
New ST-T changes on admission 1.57 –2.70 – 5.24 0.40
Intubation during the stay 7.85 0.57 – 15.13 0.04
Charlson comorbidity index (for 1 pt increase) –0.15 –0.97 – 0.68 0.73
Ejection fraction (n=172) (for 10% improvement) –1.62 –3.53 – 0.28 0.09
Length of stay (for each additional day) 0.48 0.29 – 0.68 <0.001
Table 3 Multivariate association between independent variables and evaluation and treatment score
Covariate
Difference in the proportion
of fulfilled criteria 95% CI p-value
Age category
<70 years Reference – –
70–79 years –3.26 –7.60 – 1.09 0.14
80–89 years –8.54 –12.73 – –4.35 <0.001
≥90 years –19.47 –26.76 – –12.17 <0.001
Length of stay (per day) 0.48 0.29 – 0.66 <0.001
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be refused by older patients because they logically lead to invasive
procedures, such as percutaneous or surgical interventions; in
addition, physicians may be reluctant to offer such investigations
to elderly patients, because of their frailty or because of their
shorter life expectancy. The fulfilment of the other criteria was
stable when reported to patients’ age, but none of the criteria
were fulfilled more thoroughly among older patients than among
younger ones.
Like others,1,29 we found that older patients were less frequently
transferred to an intensive care unit in the case of severe or
prolonged chest pain. In hospital, mortality of acute myocardial
infarction patients is highest among the elderly.30,31 Even
though age is a risk factor for increased mortality in the intensive
care unit after a myocardial infarction,32 transfer to such a unit
still improves survival among patients aged 70 or more when
compared to standard care in internal medicine wards.33 There
is no evidence suggesting that age alone should lower transfer
rate to an intensive care unit. Since our sample included only
patients discharged alive, we could not determine if this less
intensive management of severe chest pain had an impact on
in-hospital mortality. However, the assumption that older
patients had more comorbidities than younger patients, and
therefore were less eligible for admission to the intensive care
unit, cannot be an explanation for such decisions. Indeed, the
Charlson comorbidity index at admission was lowest among the
oldest patients. This may be explained by a greater likelihood of
the fittest reaching old age.34 Alternative explanations would be
an incomplete coding of secondary diagnoses, a known problem
among older patients,35 or coding of another principal diagnosis
than congestive heart failure in the presence of multiple co-
existing diseases.
Unlike other studies,8,9 we did not find a significantly lower use
of effective pharmaceutical therapies among the oldest patients.
Nevertheless, there was a trend for lower use of vasodilator
therapy.
Our study had several limitations. Whether the criteria of quality
of care developed by Ashton et al. are best suited to the oldest
patients can be questioned. Most clinical trials of heart failure
management exclude the oldest and the sickest patients.36,37
Therefore, the conclusions of such trials, on which expert
knowledge is at least partly built, may not fully apply to the
oldest people. The Ashton criteria are maximalist in that they
aim to determine whether a desirable investigation or treatment
was completed. However, depending on the clinical situation,
therapeutic or investigative abstention may be justified. The
reasons for such abstentions or omissions, as well as their impact
on patients’ clinical outcomes or quality of life after hospital
discharge, have not been analysed in our study, except for
hospital readmission, for which no association with evaluation
and treatment scores was found.16 Whether investigative
abstention on the basis of poor prognosis is justified deserves
further research requiring, on the one hand, the elaboration of
explicit criteria of appropriateness of such abstention due to
coexisting life threatening diseases, functional limitations or
cognitive impairment, and, on the other hand, a survey of
patients after discharge.
In conclusion, in-hospital management of heart failure was found
to be less complete for elderly patients than for younger patients,
according to an available set of explicit criteria. Physicians
should be aware of these differences and of the fact that age by
itself neither implies a poor prognosis nor is it a contraindication
for the use of effective therapy.
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